Phase Ib study of neoadjuvant concurrent chemoradiation plus durvalumab followed by surgery and adjuvant durvalumab for resectable stage III NSCLC. Results for miRNA-only XGBoost algorithm in held-out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback